IRINOTECAN SUN 1.5 mg/ml, solution for infusion bag, 180 ml
Active ingredients: Irinotecan hydrochloride trihydrate, Irinotecan
Commercialized according to BDPMDispensing in France: Prescription only
Solution for infusionbag, 180 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IRINOTECAN SUN 1,5 mg/ml, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 poche(s) unidose(s) sans-PVC suremballée(s)/surpochée(s) aluminium de 180 ml
- Marketing authorisation holder
- SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68644553CIP75507201CIP133400955072010Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'IRINOTÉCAN TRIHYDRATÉsolution | 1,5 mg · 1 mL de solution pour perfusion | SA |
| IRINOTÉCANsolution | 1,3 mg · 1 mL de solution pour perfusion | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.